PRP for Low Back Pain

Could PRP Help Your Back?

Low back pain is rarely simple — and its sources are rarely limited to a single structure. The lumbar spine is a complex system in which the intervertebral discs, nerve roots, and facet joints can each contribute to pain, often in combination.

For patients who have not found lasting relief with conservative care, PRP is a regenerative medicine alternative to corticosteroid injections across all three of these pain generators:

Dr. Murakami will evaluate the different regions of your lumbar spine to assess what is causing your discomfort. She is an expert at targeting the specific pain generators identified during your evaluation rather than defaulting to a one-size-fits-all protocol. The evaluation consists of an in-depth history, an osteopathic-based thorough physical examination, and careful correlation of your imaging with your pain generators.

This page presents the current evidence for each application honestly — including what research supports and where it falls short — because informed patients make better treatment decisions.

How PRP Works in the Spine

PRP is prepared from a small sample of your own blood, processed to concentrate the platelets and their growth factors and anti-inflammatory signaling proteins. Depending on your pain generators, PRP can be delivered in three ways:

Intradiscal PRP — injected directly into the degenerative disc under fluoroscopic guidance. The most studied application for discogenic pain. PRP may help modulate the inflammatory environment within the disc, support disc cell health, slow further degeneration, and reduce chronic discogenic pain.

Lumbar epidural PRP — injected into the epidural space around the affected spinal level, targeting inflamed nerve roots and radicular pain. This is a less invasive alternative to intradiscal injection, avoids the small risk of discitis associated with direct disc puncture, and is appropriate for patients with radiculopathy or nerve root irritation as a primary pain component.

Lumbar facet joint PRP — injected directly into the facet joints, which are small joints at the back of each vertebral level that frequently degenerate and contribute to axial low back pain. PRP may help reduce facet joint inflammation and support cartilage health in a way that provides more durable relief than corticosteroids.

PRP does not rebuild disc height, reverse structural damage, or replace surgery when surgery is clearly indicated. The goal across all three applications is biological modulation — reducing the inflammatory drivers of chronic pain and supporting the body’s own healing capacity.

What the Evidence Shows

Intradiscal PRP

The case for:

  • A systematic review of 13 RCTs and 27 non-RCTs found consistently positive results across studies — PRP demonstrated significant improvements in functional outcomes, pain relief, and patient satisfaction compared to placebo, with fewer adverse events than corticosteroids and 5+ year follow-up data available in some studies
  • A clinical trial of 31 patients found 71% achieved clinically significant improvements in pain and function at 48 weeks following a single intradiscal PRP injection
  • A multicenter, prospective, crossover RCT found intradiscal PRP significantly improved pain and function at 12 months compared to placebo
  • Long-term case series data suggests sustained benefits are possible well beyond the one to two year follow-up periods of most clinical trials

The case for caution:

  • A well-designed RCT found no significant improvement in pain or function vs. saline control at one year — specifically in patients without Modic changes on MRI. This suggests that imaging characteristics, particularly the presence of end-plate inflammatory changes, may significantly influence who responds
  • Protocol quality, PRP concentration, injection volume, and number of levels treated all appear to influence outcomes — multi-level injections are associated with less favorable results
  • Most disc regeneration trials have failed to reach publication, raising publication bias concerns
  • Discitis is a rare but serious adverse event — rigorous patient selection and sterile technique are essential

Lumbar Epidural PRP

The case for:

  • A 2025 meta-analysis of 5 RCTs including 310 patients found epidural PRP offers comparable pain relief, functional improvement, and overall health outcomes to epidural steroid injection at all observed time points — without any increase in adverse events
  • An RCT comparing epidural PRP to triamcinolone found PRP produced superior reductions in leg pain and functional improvement at 24 weeks
  • Multiple RCTs have found PRP superior to corticosteroids at the 6-month mark, suggesting PRP may provide more durable relief over time even when short-term results are similar
  • A pilot study of epidural PRP for suspected discogenic pain found 73% of patients achieved minimal clinically important differences at 12 months, with 91% satisfaction and no complications reported
  • PRP does not carry the tissue-weakening effects associated with repeated corticosteroid use — a meaningful advantage for patients requiring ongoing management

The case for caution:

  • Most epidural PRP studies have followed patients for 3–6 months only — long-term data beyond one year remains limited
  • The majority of existing studies enrolled patients with radiculopathy; evidence for epidural PRP in purely axial discogenic pain without radiculopathy is more limited
  • Larger, more rigorously controlled multicenter trials are still needed to establish standardized protocols

Lumbar Facet Joint PRP

The case for:

  • A prospective RCT found that while corticosteroid injections provided better short-term relief at one month, PRP demonstrated significantly superior pain and disability outcomes at both 3 and 6 months — suggesting PRP is the more durable option for facet-mediated low back pain
  • A study of 49 patients with facet syndrome found significant pain reduction and improved functionality at 18 months following PRP injection — with no adverse reactions reported
  • An RCT of 144 patients comparing PRP and hyaluronic acid for facet joint pain found both effective at 18 months, with PRP showing superior clinical improvement and higher patient satisfaction
  • A 2025 prospective study of CT-guided leukocyte-poor PRP injections to lumbar facet joints found significant long-term pain reduction in patients with chronic facet joint syndrome
  • An RCT found PRP injections into lumbar facet joints significantly reduced pain and improved functional outcomes compared to steroid injections, with better long-term relief at 6 and 12 months

The case for caution:

  • Current evidence for lumbar facet PRP is primarily level IV — case-control and cohort studies — with larger, more carefully controlled prospective studies still needed before definitive recommendations can be made
  • Most studies involve small sample sizes and relatively short follow-up periods
  • Evidence is less mature than for intradiscal or epidural PRP — this remains an area of active investigation

What This Means for Patient Selection

PRP for low back pain is most appropriate when:

For intradiscal PRP:

  • Chronic discogenic low back pain confirmed by clinical history and imaging
  • MRI findings including Modic changes or high intensity zones that correlate with symptoms
  • Adequate disc height retained — severe disc collapse is a contraindication
  • Single-level or limited disc involvement
  • Prior failure of conservative care and conventional injections

For epidural PRP:

  • Radiculopathy or nerve root irritation as a primary pain component
  • Prior response to epidural steroid injections that has diminished over time
  • Patients seeking a more durable alternative to repeated corticosteroid injections
  • Patients where direct disc injection carries higher procedural risk

For facet joint PRP:

  • Facet-mediated low back pain confirmed by diagnostic medial branch blocks
  • Pain pattern consistent with facet arthropathy — axial, worse with extension
  • Prior corticosteroid injections that provided short-term but not lasting relief
  • Patients where a regenerative rather than purely anti-inflammatory approach is preferred

PRP is generally not recommended for:

  • Cases where spinal surgery is immediately indicated
  • Significant neurological deficits requiring urgent intervention
  • Severe disc collapse or advanced structural instability
  • Patients with active infection, malignancy, bleeding disorders, or other procedural contraindications

Before Your Procedure

Avoid NSAIDs (such as ibuprofen, Mobic, naproxen, or Celebrex) for at least one week before and one week after your PRP procedure. NSAIDs directly counteract the inflammatory signaling that drives PRP’s effectiveness.

What to Expect

PRP spine procedures are performed at an ambulatory surgery center (ASC) under fluoroscopic guidance. A small blood sample is drawn, processed on-site to concentrate the platelets, and injected into the disc, epidural space, or facet joints as appropriate for your clinical picture. Antibiotic prophylaxis is administered for intradiscal procedures to minimize infection risk.

Most patients return to light activity within a few days. Mild soreness at the injection site is common. Meaningful improvements typically develop gradually over four to twelve weeks, with some patients reporting continued gains over several months. Long-term data suggests sustained benefits are possible for patients who respond to treatment.

From a Research & Clinical Perspective

The evidence for lumbar epidural and facet joint PRP is generally consistent — multiple RCTs support PRP as comparable or superior to corticosteroids, with more durable long-term results across both applications. The evidence for intradiscal PRP is more mixed — a systematic review of 40 studies reports consistently positive outcomes, but a well-designed RCT found no benefit over saline in patients without Modic changes, underscoring the critical importance of patient selection. Across all three applications, larger controlled trials with standardized protocols are needed.

Dr. Murakami will review the current evidence alongside her clinical experience to discuss which application — or combination of applications — is most appropriate for your specific presentation.

Sources & Further Reading

The following peer-reviewed studies informed the content on this page. Links open in a new tab.

Intradiscal PRP — Supporting Evidence

  • Navani A, et al. (2024). The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover RCT with 12 Months Follow-up. Pain Physician.

Intradiscal PRP — Negative and Limiting Evidence

Epidural PRP — Supporting Evidence

  • Wongjarupong A, et al. (2023). Platelet-Rich Plasma Epidural Injection: An Emerging Strategy in Lumbar Disc Herniation — A Randomized Controlled Trial. BMC Musculoskeletal Disorders. (PRP superior to triamcinolone in leg pain reduction and function at 24 weeks.)

Epidural PRP — Limitations

Facet Joint PRP — Supporting Evidence

Facet Joint PRP — Limitations

  • Platelet-Rich Plasma Injections: Pharmacological and Clinical Considerations in Pain Management. (2022). PubMed. (Current evidence primarily level IV — larger, more carefully controlled prospective studies still needed.)

This page was last reviewed March 2026.

Consultation on PRP for Low Back Pain with Dr. Murakami